Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor [9]

AIDS

Volumn 21, Issue 12, 2007, Pages 1666-1669

  Merchant, Shehzad ^a   Reichman, Richard ^a   Koval, Christine E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; PREDNISONE; VICRIVIROC;

ADULT; BIOPSY; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; MALE; MUCORMYCOSIS; NEPHROTOXICITY; PRIORITY JOURNAL; RHIZOPUS; TREATMENT REFUSAL; TREATMENT RESPONSE; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; FATAL OUTCOME; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; RECEPTORS, CCR5; ZYGOMYCOSIS;

EID: 34447537985     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328274257b     Document Type: Letter

References (10)

1. Abril V, Ortega E, Segarra P, Pedro F, Sabater V, Herrera A. Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy. Clin Infect Dis 1996; 23:845-846.
2. Blatt SP, Lucey DR, DeHoff D, Zellmer RB. Rhinocerebral zygomycosis in a patient with AIDS. J Infect Dis 1991; 164:215-216.
3. Boumis E, Chinello P, Conte A, Noto P, Cicalini S, Grillo LR, et al. Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature review. AIDS 2006; 20:136-138.
4. Lee BL, Holland GN, Glasgow BJ. Chiasmal infarction and sudden blindness caused by mucormycosis in AIDS and diabetes mellitus. Am J Ophthalmol 1996; 122:895-896.
5. Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: a case of mucormycosis. Cutis 2000; 66:15-18.
6. Pedro-de-Lelis FJ, Sabater-Marco V, Herrera-Ballester A. Necrotizing maxillary sinus mucormycosis related to candidiasis and microsporidiosis in an AIDS patient. AIDS 1995; 9:1386-1388.
7. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634-653.
8. Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun 2005; 73:3714-3724.
9. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, et al. CCR5 deficiency increases risk of symptomatic west nile virus infection. J Exp Med 2006; 203:35-40.
10. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50:126-133.